Leo Pharma A/S - search results

United States - English - NLM (National Library of Medicine)

protopic- tacrolimus ointment

leo pharma inc - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.3 mg in 1 g - protopic® ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic® ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic® ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Australia - English - Department of Health (Therapeutic Goods Administration)

daivonex calcipotriol (as monohydrate) 50 microgram/g cream tube

leo pharma pty ltd - calcipotriol -

Australia - English - Department of Health (Therapeutic Goods Administration)

fucidin sodium fusidate 20mg/g ointment tube

leo pharma pty ltd - sodium fusidate, quantity: 20 mg/g - ointment - excipient ingredients: white soft paraffin; cetyl alcohol; wool fat; liquid paraffin - skin lesions primarily and secondarily infected with staphylococci, e.g. abscesses, boils, furunculosis, impetigo, folliculitis, hidradenitis, pyoderma, sycosis barbae, otitis externa.

New Zealand - English - Medsafe (Medicines Safety Authority)

nerisone

leo pharma limited - diflucortolone valerate 0.1% - topical cream - 0.1 % - active: diflucortolone valerate 0.1% excipient: carbomer disodium edetate dihydrate liquid paraffin macrogol stearate 2000 methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide stearyl alcohol white soft paraffin - all skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites.

New Zealand - English - Medsafe (Medicines Safety Authority)

nerisone fatty

leo pharma limited - diflucortolone valerate 0.1% - topical ointment - 0.1 % - active: diflucortolone valerate 0.1% excipient: hydrogenated castor oil liquid paraffin microcrystalline wax white soft paraffin - all skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites.